
Jan Aushadhi centres warn of closure if private company medicines are banned. Owners cite PMBI supply shortages and fear disruption in affordable healthcare services. HEALTH TOP NEWS
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international tr…